UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Synthesis and preclinical evaluation of BOLD-100 radiolabeled with ruthenium-97 and ruthenium-103

Dalton transactions : an international journal of inorganic chemistry, 2024-03, Vol.53 (13), p.631-64

2024

Volltextzugriff (PDF)

Recent Developments in the Field of Tumor-Inhibiting Metal Complexes

Current pharmaceutical design, 2003-10, Vol.9 (25), p.2078-2089

2003

Volltextzugriff (PDF)

Self-assembled Pt2L2 boxes strongly bind G-quadruplex DNA and influence gene expression in cancer cells

Dalton transactions : an international journal of inorganic chemistry, 2017, Vol.46 (2), p.329-332

2017

Volltextzugriff (PDF)

Multi-scale imaging of anticancer platinum() compounds in murine tumor and kidney

Chemical science (Cambridge), 2016-01, Vol.7 (5), p.352-361

2016

Volltextzugriff (PDF)

Heterocyclic complexes of ruthenium(III) induce apoptosis in colorectal carcinoma cells

Journal of cancer research and clinical oncology, 2005-02, Vol.131 (2), p.101-110

2005

Volltextzugriff (PDF)

Triapine-mediated ABCB1 induction via PKC induces widespread therapy unresponsiveness but is not underlying acquired triapine resistance

Cancer letters, 2015-05, Vol.361 (1), p.112-120

2015

Volltextzugriff (PDF)

Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24)

Biochemical pharmacology, 2007-06, Vol.73 (12), p.1873-1886

2007

Volltextzugriff (PDF)

Tumour-inhibiting platinum complexes--state of the art and future perspectives

Reviews of physiology, biochemistry and pharmacology, 2003-01, Vol.146, p.1

2003

Volltextzugriff (PDF)

Nanoformulation improves activity of the (pre)clinical anticancer ruthenium complex KP1019

Journal of biomedical nanotechnology, 2014-05, Vol.10 (5), p.877-884

2014

Volltextzugriff (PDF)

Intrinsic and acquired forms of resistance against the anticancer ruthenium compound KP1019 [indazolium trans-[tetrachlorobis(1H-indazole)ruthenate (III)] (FFC14A)

The Journal of pharmacology and experimental therapeutics, 2005-01, Vol.312 (1), p.281-289

2005

Volltextzugriff (PDF)

A comparative study of adduct formation between the anticancer ruthenium(III) compound HInd trans-[RuCl 4(Ind) 2] and serum proteins

Journal of inorganic biochemistry, 2004-06, Vol.98 (6), p.1135-1142

2004

Volltextzugriff (PDF)

Improved reaction conditions for the synthesis of new NKP-1339 derivatives and preliminary investigations on their anticancer potential

Dalton transactions : an international journal of inorganic chemistry, 2015-01, Vol.44 (2), p.659-668

2015

Volltextzugriff (PDF)

Species specific IDMS for accurate quantification of carboplatin in urine by LC-ESI-TOFMS and LC-ICP-QMS

Journal of analytical atomic spectrometry, 2008-01, Vol.23 (1), p.29-36

2008

Volltextzugriff (PDF)

Structure elucidation and quantification of the reduction products of anticancer Pt(iv) prodrugs by electrochemistry/mass spectrometry (EC-MS)

Analyst (London), 2018-05, Vol.143 (9), p.1997-2001

2018

Volltextzugriff (PDF)

Loss of CUL4A expression is underlying cisplatin hypersensitivity in colorectal carcinoma cells with acquired trabectedin resistance

British journal of cancer, 2017-02, Vol.116 (4), p.489-500

2017

Volltextzugriff (PDF)

Structure elucidation and quantification of the reduction products of anticancer Pt(iv) prodrugs by electrochemistry/mass spectrometry (EC-MS)Electronic supplementary information (ESI) available: Experimental part, mass voltammograms, EC-LC-MS analysis. See DOI: 10.1039/c8an00258d

Analyst (London), 2018-04, Vol.143 (9), p.1997-21

2018

Volltextzugriff (PDF)

HPIC-UV-ICP-SFMS study of the interaction of cisplatin with guanosine monophosphate

Analytical and bioanalytical chemistry, 2001-07, Vol.370 (5), p.581-586

2001

Volltextzugriff (PDF)

Carboxylation of Dihydroxoplatinum(IV) Complexes via a New Synthetic Pathway

Inorganic chemistry, 1996-03, Vol.35 (6), p.1709-1711

1996

Volltextzugriff (PDF)

Self-assembled Pt 2 L 2 boxes strongly bind G-quadruplex DNA and influence gene expression in cancer cells

Dalton transactions : an international journal of inorganic chemistry, 2017-01, Vol.46 (2), p.329-332

2017

Volltextzugriff (PDF)

Pharmacological properties of cerium compounds

Reviews of physiology, biochemistry and pharmacology, 2005-01, Vol.153, p.101

2005

Volltextzugriff (PDF)

Metallodrug research and analysis using capillary electrophoresis

TrAC, Trends in analytical chemistry (Regular ed.), 2006-10, Vol.25 (9), p.868-875

2006

Volltextzugriff (PDF)

Preclinical activity of trans-indazolium [tetrachlorobisindazoleruthenate(III)] (NSC 666158; IndCR; KP 1019) against tumour colony-forming units and haematopoietic progenitor cells

European journal of cancer (1990), 1997-12, Vol.33 (14), p.2404-2410

1997

Volltextzugriff (PDF)

Kinetics of binding properties of 5′-GMP with cisplatin under simulated physiological conditions by capillary electrophoresis

Journal of chromatography. B, Biomedical sciences and applications, 2000-08, Vol.745 (1), p.211-219

2000

Volltextzugriff (PDF)

Preclinical toxicology and tissue gallium distribution of a novel antitumour gallium compound: tris (8-quinolinolato) gallium (III)

Anticancer research, 1996-03, Vol.16 (2), p.687

1996

Volltextzugriff (PDF)

Ribonucleotide reductase as one important target of [Tris(1,10-phenanthroline)lanthanum(III)] trithiocyanate (KP772)

Current cancer drug targets, 2009-08, Vol.9 (5), p.595-607

2009

Volltextzugriff (PDF)

1 – 25 von 417

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(379)
Mit Volltextzugriff
(367)

Publikationsform

Sprache

Englisch
(404)
Deutsch
(12)
Russisch
(1)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Synthesis and preclinical evaluation of BOLD-100 radiolabeled with ruthenium-97 and ruthenium-103

Recent Developments in the Field of Tumor-Inhibiting Metal Complexes

Self-assembled Pt2L2 boxes strongly bind G-quadruplex DNA and influence gene expression in cancer cells

Multi-scale imaging of anticancer platinum() compounds in murine tumor and kidney

Heterocyclic complexes of ruthenium(III) induce apoptosis in colorectal carcinoma cells

Triapine-mediated ABCB1 induction via PKC induces widespread therapy unresponsiveness but is not underlying acquired triapine resistance

Multidrug-resistant cancer cells are preferential targets of the new antineoplastic lanthanum compound KP772 (FFC24)

Tumour-inhibiting platinum complexes--state of the art and future perspectives

Nanoformulation improves activity of the (pre)clinical anticancer ruthenium complex KP1019

Intrinsic and acquired forms of resistance against the anticancer ruthenium compound KP1019 [indazolium trans-[tetrachlorobis(1H-indazole)ruthenate (III)] (FFC14A)

A comparative study of adduct formation between the anticancer ruthenium(III) compound HInd trans-[RuCl 4(Ind) 2] and serum proteins

Improved reaction conditions for the synthesis of new NKP-1339 derivatives and preliminary investigations on their anticancer potential

Species specific IDMS for accurate quantification of carboplatin in urine by LC-ESI-TOFMS and LC-ICP-QMS

Structure elucidation and quantification of the reduction products of anticancer Pt(iv) prodrugs by electrochemistry/mass spectrometry (EC-MS)

Loss of CUL4A expression is underlying cisplatin hypersensitivity in colorectal carcinoma cells with acquired trabectedin resistance

Structure elucidation and quantification of the reduction products of anticancer Pt(iv) prodrugs by electrochemistry/mass spectrometry (EC-MS)Electronic supplementary information (ESI) available: Experimental part, mass voltammograms, EC-LC-MS analysis. See DOI: 10.1039/c8an00258d

HPIC-UV-ICP-SFMS study of the interaction of cisplatin with guanosine monophosphate

Carboxylation of Dihydroxoplatinum(IV) Complexes via a New Synthetic Pathway

Self-assembled Pt 2 L 2 boxes strongly bind G-quadruplex DNA and influence gene expression in cancer cells

Pharmacological properties of cerium compounds

Metallodrug research and analysis using capillary electrophoresis

Preclinical activity of trans-indazolium [tetrachlorobisindazoleruthenate(III)] (NSC 666158; IndCR; KP 1019) against tumour colony-forming units and haematopoietic progenitor cells

Kinetics of binding properties of 5′-GMP with cisplatin under simulated physiological conditions by capillary electrophoresis

Preclinical toxicology and tissue gallium distribution of a novel antitumour gallium compound: tris (8-quinolinolato) gallium (III)

Ribonucleotide reductase as one important target of [Tris(1,10-phenanthroline)lanthanum(III)] trithiocyanate (KP772)

Suchergebnisse filtern